Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 77,978 shares at $35.01 ($2.7M) on 2025-10-28, disclosed to the SEC on 2025-10-28.
Open-market sale of $2.7M VKTX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.01 | 38,989 | $1.4M | 50.0% |
| 2 | $35.01 | 38,989 | $1.4M | 50.0% |
| Total | $35.01 avg | 77,978 | $2.7M | 100% |
| Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |
| VKTX | SELL | 2024-09-20 | $30.6M | — | Filing → |